| Catalog Number | CBCL-582 |
| Price | Online Inquiry |
| Unit Quantity | 1x106 cells / 1.0 ml |
Stable RS4;11 expressing exogenous BCL2 gene bearing G101V amino acid mutation.
Drug screening and biological assays
Bcl-2 (B-cell lymphoma 2), as it is the second member of a range of proteins initially described in chromosomal translocations involving chromosomes 14 and 18 in follicular lymphomas. Bcl-2-family proteins regulate all major types of cell death, including apoptosis, necrosis and autophagy, thus operating as nodal points at the convergence of multiple pathways with broad relevance to oncology.
| Category | Immune Molecules Cell Lines |
| Cell Line Name | BCL2-G101V Stable RS4;11 Cell Line |
| Pharmaceutical Target | Immune Molecules |
| Species | Human |
| Host Cell Line | RS4;11 |
| Cell Type | Acute lymphoblastic leukemia, Lymphoblast |
| Morphology | lymphoblastoid |
| Growth Properties | Suspension |
| Selection Marker | Puromycin |
| Seeding Density | Thaw entire contents into an appropriate T25 flask. |
| Subculture Ratio | Recommended a ratio of 1:3. |
| Recommended Medium | RPMI1640 + 10% FBS + 1 μg/ml Puromycin |
| Storage Method | Frozen in liquid nitrogen with 70% medium, 20% FBS and 10% DMSO |
| Stability | Stable in culture over 10 passages |
| QC | WB |
| Shipping | Shipping in dry ice |
| Biosafety Level | BSL-1 |
| Caution | For Research Use Only |